What's Happening?
Dr. Sadhna Bokhiria, CEO of KIRIA Advisory Partners, has been accepted into the Forbes Business Council. This membership provides her with exclusive opportunities to collaborate with respected leaders and contribute expert insights to Forbes.com. Dr. Bokhiria has a decade of experience in oncology, focusing on the psychosocial factors of cancer care. Her leadership at KIRIA Advisory Partners has expanded the firm's reach into the UK, Canada, and the EU, while leading healthcare strategy in the U.S. The firm specializes in health-system decision intelligence and commercialization strategy for biotech and pharmaceutical corporations. Dr. Bokhiria is recognized for integrating evidence-based leadership principles into enterprise strategy, drawing on the neuroscience of laughter.
Why It's Important?
Dr. Bokhiria's acceptance into the Forbes Business Council underscores her influence in the healthcare and biopharma sectors. Her participation in the council could enhance KIRIA Advisory Partners' strategic capabilities, fostering innovation and collaboration across global markets. This development may lead to increased visibility and credibility for the firm, potentially attracting new partnerships and clients. Dr. Bokhiria's insights on health-system decision intelligence and oncology commercialization could shape industry practices, influencing how biopharma companies approach market access and pricing strategies in the U.S. and internationally.
What's Next?
As a council member, Dr. Bokhiria will publish applied insights for biopharma leaders, focusing on health-system decision intelligence and oncology commercialization. Her contributions to Forbes.com may impact industry discussions and strategies, particularly in the context of IRA-era market access and pricing. KIRIA Advisory Partners is expected to continue expanding its influence in the healthcare sector, leveraging Dr. Bokhiria's expertise to drive meaningful innovation and reduce uncertainty in integrated delivery networks and community cancer centers.